Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Jaime S. Green"'
Publikováno v:
Case Reports in Infectious Diseases, Vol 2015 (2015)
Background. De novo and donor-derived invasive fungal infections (IFIs) contribute to morbidity and mortality in solid organ transplant (SOT) recipients. Reporting of donor-derived IFIs (DDIFIs) to the Organ Procurement Transplant Network has been ma
Externí odkaz:
https://doaj.org/article/13d2273a159441118946e7de19d93773
Publikováno v:
Current Treatment Options in Pediatrics. 8:211-231
Autor:
Marcie L. Riches, Jaime S. Green, Maheen Z. Abidi, Dwight E Yin, Taiga Nishihori, Min Chen, Celalettin Ustun, Caroline A. Lindemans, John R. Wingard, Joshua A. Hill, Baldeep Wirk, Robert Peter Gale, Usama Gergis, Richard F. Olsson, Parameswaran Hari, Hillard M. Lazarus, Gerhard C. Hildebrandt, Jeffrey Auletta, Krishna V. Komanduri, Sachiko Seo, David Marks, Minoo Battiwala, Miguel Angel Diaz, Parastoo B. Dahi, Jean A. Yared, Soyoung Kim, Siddhartha Ganguly
Publikováno v:
Bone Marrow Transplantation, 54(8), 1354. Nature Publishing Group
Bone marrow transplantation, vol 54, iss 8
Bone marrow transplantation, vol 54, iss 8
Limited data exist on characteristics of central nervous system viruses (CNS-V) in allogeneic hematopoietic stem cell transplant (HCT) recipients. Between 2007 and 2015, the Center for International Blood and Marrow Transplant Research (CIBMTR) recei
Autor:
Ricardo M. La Hoz, Jaime S. Green, Theresa Benedict, Elizabeth B. Gray, Holenarasipur R. Vikram, Hilda N. Rivera, Susan P. Montgomery
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 20(6)
BACKGROUND: Heart transplantation has been shown to be a safe and effective intervention for progressive cardiomyopathy from chronic Chagas disease. However, in the presence of the immunosuppression required for heart transplantation, the likelihood
Autor:
Qing Cao, Erica D. Warlick, Bassil Said, Jeffrey S. Miller, Nelli Bejanyan, Jaime S. Green, Maryam Ebadi, Ryan Shanley, Julie M. Curtsinger, Armin Rashidi, Claudio G. Brunstein, Daniel J. Weisdorf
Approximately 75% of cord blood transplant (CBT) recipients experience human herpes virus-6 (HHV-6) reactivation. Considering the immunomodulatory effects of HHV-6, we hypothesized that early HHV-6 reactivation may influence the risk of relapse of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c5d1c3a52614f5f178ce50db77fc7c1
https://europepmc.org/articles/PMC6235732/
https://europepmc.org/articles/PMC6235732/
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(3)
Mycotic aneurysms are a fatal manifestation of disseminated fungal infections in immunocompromised hosts. We present a patient with an Aspergillus mycotic aneurysm after hematopoietic cell transplant. Due to CYP2C19 rapid metabolizer phenotype (*1/*1
Autor:
Jo Anne H. Young, Jaime S Green
Publikováno v:
DeckerMed Medicine.
Yeast-based fungal infections have become increasingly important over several decades, paradoxically because advances in medical practice have allowed patients with chronic medical conditions to live longer and have more productive lives. Many of the
Publikováno v:
Neoplastic Diseases of the Blood ISBN: 9783319642628
Bacterial and fungal infections continue to be an unwelcome complication of the treatment of patients with hematological malignancies despite much progress in the oncologic management in recent years. Some new treatment advances and modalities have o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afa4a2fd375467340e139e67f6f789cb
https://doi.org/10.1007/978-3-319-64263-5_50
https://doi.org/10.1007/978-3-319-64263-5_50
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:S135-S136
Publikováno v:
Transplant Infectious Disease. 21:e13070
Recovery of cytomegalovirus (CMV)-specific immunity after hematopoietic cell transplantation (HCT) is essential in controlling CMV infection. We hypothesize that mixed donor engraftment as measured by chimerism at day 30 in CMV D(+) HCTs and full chi